ReviewCureus2024

Semaglutide Versus Other Glucagon-Like Peptide-1 Agonists for Weight Loss in Type 2 Diabetes Patients: A Systematic Review and Meta-Analysis.

Jimmy Wen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.